{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:08:30Z","timestamp":1792242510382,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09700-y","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T01:32:55Z","timestamp":1760405575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Characterisation and diagnostic model of monogenic lupus"],"prefix":"10.1007","volume":"73","author":[{"given":"Mengyang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"9700_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108274","volume":"209","author":"EMD Smith","year":"2019","unstructured":"Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274. https:\/\/doi.org\/10.1016\/j.clim.2019.108274.","journal-title":"Clin Immunol"},{"key":"9700_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2021.108907","volume":"234","author":"T Alexander","year":"2021","unstructured":"Alexander T, Hedrich CM. Systemic lupus erythematosus \u2013 Are children miniature adults? Clin Immunol. 2021;234:108907. https:\/\/doi.org\/10.1016\/j.clim.2021.108907.","journal-title":"Clin Immunol"},{"key":"9700_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/bor.0000000000001008","volume":"36","author":"Y Qin","year":"2024","unstructured":"Qin Y, Ma J, Vinuesa CG. Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. Curr Opin Rheumatol. 2024;36:191\u2013200. https:\/\/doi.org\/10.1097\/bor.0000000000001008.","journal-title":"Curr Opin Rheumatol"},{"key":"9700_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","volume":"49","author":"P Costa-Reis","year":"2017","unstructured":"Costa-Reis P, Sullivan KE. Monogenic lupus: it\u2019s all new! Curr Opin Rheumatol. 2017;49:87\u201395. https:\/\/doi.org\/10.1016\/j.coi.2017.10.008.","journal-title":"Curr Opin Rheumatol"},{"key":"9700_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109699","volume":"254","author":"X Jia","year":"2023","unstructured":"Jia X, Tan L, Chen S, Tang R, Chen W. Monogenic lupus: tracing the therapeutic implications from single gene mutations. Clin Immunol. 2023;254:109699. https:\/\/doi.org\/10.1016\/j.clim.2023.109699.","journal-title":"Clin Immunol"},{"key":"9700_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10875-024-01696-8","volume":"44","author":"M Tusseau","year":"2024","unstructured":"Tusseau M, Khaldi-Plassart S, Cognard J, Viel S, Khoryati L, Benezech S, et al. Mendelian causes of autoimmunity: the Lupus phenotype. J Clin Immunol. 2024;44:99. https:\/\/doi.org\/10.1007\/s10875-024-01696-8.","journal-title":"J Clin Immunol"},{"key":"9700_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030712","volume":"9","author":"E Demirkaya","year":"2020","unstructured":"Demirkaya E, Sahin S, Romano M, Zhou Q, Aksentijevich I. New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond. J Clin Med. 2020;9:712. https:\/\/doi.org\/10.3390\/jcm9030712.","journal-title":"J Clin Med"},{"key":"9700_CR8","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jaci.2022.12.807","volume":"151","author":"CY Wu","year":"2022","unstructured":"Wu CY, Fan WL, Yang HY, Chu PS, Liao PC, Chen LC, et al. Contribution of genetic variants associated with primary immunodeficiencies to childhood-onset systemic lupus erythematous. J Allergy Clin Immunol. 2022;151:1123\u201331. https:\/\/doi.org\/10.1016\/j.jaci.2022.12.807.","journal-title":"J Allergy Clin Immunol"},{"key":"9700_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102361","volume":"18","author":"O Omarjee","year":"2019","unstructured":"Omarjee O, Picard C, Frachette C, Moreews M, Rieux-Laucat F, Soulas-Sprauel P, et al. Monogenic lupus: dissecting heterogeneity. Autoimmun Rev. 2019;18:102361. https:\/\/doi.org\/10.1016\/j.autrev.2019.102361.","journal-title":"Autoimmun Rev"},{"key":"9700_CR10","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s12519-024-00817-y","volume":"20","author":"TY Zhang","year":"2024","unstructured":"Zhang TY, Wang W, Gao SH, Yu ZX, Wang W, Zhou Y, et al. Lasso-derived nomogram for early identification of pediatric monogenic lupus. World J Pediatr. 2024;20:1155\u201367. https:\/\/doi.org\/10.1007\/s12519-024-00817-y.","journal-title":"World J Pediatr"},{"key":"9700_CR11","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/09612033231211065","volume":"32","author":"SM Al-Mayouf","year":"2023","unstructured":"Al-Mayouf SM, Alkhars F, AlSaleem A. Phenotype and disease course differences in monogenic and sporadic childhood lupus. Lupus. 2023;32:1548\u201354. https:\/\/doi.org\/10.1177\/09612033231211065.","journal-title":"Lupus"},{"key":"9700_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.35745\/ijcmb2022v02.02.0002","volume":"2","author":"L Akbar","year":"2022","unstructured":"Akbar L, Al-Mayouf SM. Monogenic lupus is a construct: insights into the current nomenclature and classification. International Journal of Clinical Medicine and Bioengineering. 2022;2:20\u20136. https:\/\/doi.org\/10.35745\/ijcmb2022v02.02.0002.","journal-title":"International Journal of Clinical Medicine and Bioengineering"},{"key":"9700_CR13","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against Rheumatism\/American college of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400\u201312. https:\/\/doi.org\/10.1002\/art.40930.","journal-title":"Arthritis Rheumatol"},{"key":"9700_CR14","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai A, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677\u201386. https:\/\/doi.org\/10.1002\/art.34473.","journal-title":"Arthritis Rheum"},{"key":"9700_CR15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/acr.23894","volume":"72","author":"WM Lambers","year":"2019","unstructured":"Lambers WM, Westra J, Jonkman MF, Bootsma H, De Leeuw K. Incomplete systemic lupus erythematosus: What remains After application of American College of Rheumatology and Systemic Lupus International Collaborating Clinics criteria? Arthritis Care Res. 2019;72:607\u201314. https:\/\/doi.org\/10.1002\/acr.23894.","journal-title":"Arthritis Care Res"},{"key":"9700_CR16","doi-asserted-by":"publisher","unstructured":"Pavlou M, Ambler G, Seaman SR, Guttmann O, Elliott P, King M, et al. How to develop a more accurate risk prediction model when there are few events. BMJ. 2015;351:h3868. soi:https:\/\/doi.org\/10.1136\/bmj.h3868","DOI":"10.1136\/bmj.h3868"},{"key":"9700_CR17","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35:1925\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/ehu207.","journal-title":"Eur Heart J"},{"key":"9700_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.ekir.2019.04.014","volume":"4","author":"SBE Khalifi","year":"2019","unstructured":"Khalifi SBE, Viel S, Lahoche A, Fr\u00e9mond ML, Lopez J, Lombard C, et al. Copa syndrome as a cause of lupus nephritis. Kidney Int Rep. 2019;4:1187\u20139. https:\/\/doi.org\/10.1016\/j.ekir.2019.04.014.","journal-title":"Kidney Int Rep"},{"key":"9700_CR19","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/art.39110","volume":"67","author":"L Van Eyck","year":"2015","unstructured":"Van Eyck L, De Somer L, Pombal D, Bornschein S, Frans G, Humblet-Baron S, et al. Brief report: IFIH1 mutation causes systemic lupus erythematosus with selective IgA deficiency. Arthritis Rheum. 2015;67:1592\u20137. https:\/\/doi.org\/10.1002\/art.39110.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9700_CR20","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s10875-021-01019-1","volume":"41","author":"SM Al-Mayouf","year":"2021","unstructured":"Al-Mayouf SM, Akbar L, AlEnazi A, Al-Mousa H. Autosomal recessive ISG15 deficiency underlies type I interferonopathy with systemic lupus erythematosus and inflammatory myositis. J Clin Immunol. 2021;41(6):1361\u20134. https:\/\/doi.org\/10.1007\/s10875-021-01019-1.","journal-title":"J Clin Immunol"},{"key":"9700_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18925-4","volume":"11","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj J, Castro CN, Tusseau M, Stolzenberg MC, Mazerolles F, Aladjidi N, et al. Early-onset autoimmunity associated with SOCS1 haploinsufficiency. Nat Commun. 2020;11:5341. https:\/\/doi.org\/10.1038\/s41467-020-18925-4.","journal-title":"Nat Commun"},{"key":"9700_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103119","volume":"140","author":"Y Du","year":"2023","unstructured":"Du Y, Brodeur KE, Hsu E, Chen L, Chen Q, Liu M, et al. In cis \u201cbenign\u201d SOCS1 variants linked to enhanced interferon signaling and autoimmunity. J Autoimmun. 2023;140:103119. https:\/\/doi.org\/10.1016\/j.jaut.2023.103119.","journal-title":"J Autoimmun"},{"key":"9700_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0349-y","volume":"17","author":"I Tirosh","year":"2019","unstructured":"Tirosh I, Spielman S, Barel O, Ram R, Stauber T, Paret G, et al. Whole exome sequencing in childhood-onset lupus frequently detects single gene etiologies. Pediatr Rheumatol. 2019;17:52. https:\/\/doi.org\/10.1186\/s12969-019-0349-y.","journal-title":"Pediatr Rheumatol"},{"key":"9700_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaut.2019.01.011","volume":"99","author":"L Amaya-Uribe","year":"2019","unstructured":"Amaya-Uribe L, Rojas M, Azizi G, Anaya JM, Gershwin ME. Primary immunodeficiency and autoimmunity: a comprehensive review. J Autoimmun. 2019;99:52\u201372. https:\/\/doi.org\/10.1016\/j.jaut.2019.01.011.","journal-title":"J Autoimmun"},{"key":"9700_CR25","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41423-020-00626-z","volume":"18","author":"G Sogkas","year":"2021","unstructured":"Sogkas G, Atschekzei F, Adriawan IR, Dubrowinskaja N, Witte T, Schmidt RE. Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity. Cell Mol Immunol. 2021;18:1122\u201340. https:\/\/doi.org\/10.1038\/s41423-020-00626-z.","journal-title":"Cell Mol Immunol"},{"key":"9700_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.55563\/clinexprheumatol\/zte897","volume":"39","author":"G Li","year":"2021","unstructured":"Li G, Liu H, Li Y, Zhang T, Yao W, Guan W, et al. Genetic heterogeneity in Chinese children with systemic lupus erythematosus. Clin Exp Rheumatol. 2021;39:214\u201322. https:\/\/doi.org\/10.55563\/clinexprheumatol\/zte897.","journal-title":"Clin Exp Rheumatol"},{"key":"9700_CR27","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/annrheumdis-2021-221814","volume":"81","author":"KC Gedik","year":"2022","unstructured":"Gedik KC, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S, et al. The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE\/PRAAS, SAVI and AGS. Ann Rheum Dis. 2022;81:601\u201313. https:\/\/doi.org\/10.1136\/annrheumdis-2021-221814.","journal-title":"Ann Rheum Dis"},{"key":"9700_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jaci.2023.11.004","volume":"153","author":"A Magerus","year":"2023","unstructured":"Magerus A, Rensing-Ehl A, Rao VK, Teachey DT, Rieux-Laucat F, Ehl S. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders. J Allergy Clin Immunol. 2023;153:67\u201376. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.004.","journal-title":"J Allergy Clin Immunol"},{"key":"9700_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.autrev.2018.02.012","volume":"17","author":"F Berteau","year":"2018","unstructured":"Berteau F, Rouviere B, Delluc A, Nau A, Berre RL, Sarrabay G, et al. Autosomic dominant familial Beh\u00e7et disease and haploinsufficiency A20: a review of the literature. Autoimmun Rev. 2018;17:809\u201315. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.012.","journal-title":"Autoimmun Rev"},{"key":"9700_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/annrheumdis-2016-210944","volume":"77","author":"CJA Duncan","year":"2017","unstructured":"Duncan CJA, Dinnigan E, Theobald R, Grainger A, Skelton AJ, Hussain R, et al. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20). Annal Rheum Dis. 2017;77:783\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210944.","journal-title":"Annal Rheum Dis"},{"key":"9700_CR31","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jaci.2009.12.983","volume":"125","author":"I Caminha","year":"2010","unstructured":"Caminha I, Fleisher TA, Hornung RL, Dale JK, Niemela JE, Price S, et al. Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome. J Allergy Clin Immunol. 2010;125:946-9.e6. https:\/\/doi.org\/10.1016\/j.jaci.2009.12.983.","journal-title":"J Allergy Clin Immunol"},{"key":"9700_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12016-019-08738-9","volume":"59","author":"M Jamee","year":"2019","unstructured":"Jamee M, Moniri S, Zaki-Dizaji M, Olbrich P, Yazdani R, Jadidi-Niaragh F, et al. Clinical, immunological, and genetic features in patients with activated PI3K\u03b4 syndrome (APDS): a systematic review. Clin Rev Allergy Immunol. 2019;59:323\u201333. https:\/\/doi.org\/10.1007\/s12016-019-08738-9.","journal-title":"Clin Rev Allergy Immunol"},{"key":"9700_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","volume":"41","author":"Q Neven","year":"2020","unstructured":"Neven Q, Boulanger C, Bruwier A, De Ville De Goyet M, Meyts I, Moens L, et al. Clinical spectrum of RAS-associated autoimmune leukoproliferative disorder (RALD). J Clin Immunol. 2020;41:51\u20138. https:\/\/doi.org\/10.1007\/s10875-020-00883-7.","journal-title":"J Clin Immunol"},{"key":"9700_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0346-1","volume":"17","author":"W Wang","year":"2019","unstructured":"Wang W, Zhou Y, Zhong L, Wang L, Tang X, Ma M, et al. RAS-associated autoimmune leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children. Pediatr Rheumatol. 2019;17:55. https:\/\/doi.org\/10.1186\/s12969-019-0346-1.","journal-title":"Pediatr Rheumatol"},{"key":"9700_CR35","doi-asserted-by":"publisher","unstructured":"Driessen GJ, IJspeert H, Wentink M, Yntema HG, Van Hagen PM, Van Strien A, et al. Increased PI3K\/Akt activity and deregulated humoral immune response in human PTEN deficiency. J Allergy Clin Immunol. 2016;138:1744\u20137.e5. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.010","DOI":"10.1016\/j.jaci.2016.07.010"},{"key":"9700_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.09.002","volume":"88","author":"ML Fr\u00e9mond","year":"2020","unstructured":"Fr\u00e9mond ML, Nathan N. COPA syndrome, 5 years after: Where are we? Joint Bone Spine. 2020;88:105070. https:\/\/doi.org\/10.1016\/j.jbspin.2020.09.002.","journal-title":"Joint Bone Spine"},{"key":"9700_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/jci163604","volume":"134","author":"S Delafontaine","year":"2024","unstructured":"Delafontaine S, Iannuzzo A, Bigley TM, Mylemans B, Rana R, Baatsen P, et al. Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoin\ufb02ammatory syndrome. J Clin Invest. 2024;134:e163604. https:\/\/doi.org\/10.1172\/jci163604.","journal-title":"J Clin Invest"},{"issue":"6","key":"9700_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107633","volume":"31","author":"M Martin-Fernandez","year":"2020","unstructured":"Martin-Fernandez M, Garc\u00eda-Morato MB, Gruber C, Loza SM, Malik MNH, Alsohime F, et al. Systemic type I IFN inflammation in human ISG15 deficiency leads to necrotizing skin lesions. Cell Rep. 2020;31(6):107633. https:\/\/doi.org\/10.1016\/j.celrep.2020.107633.","journal-title":"Cell Rep"},{"key":"9700_CR39","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Gomez ML, Becerra JCA, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154\u201364. https:\/\/doi.org\/10.1182\/blood-2015-11-679902.","journal-title":"Blood"},{"key":"9700_CR40","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/humu.23975","volume":"41","author":"GI Rice","year":"2020","unstructured":"Rice GI, Park S, Gavazzi F, Adang LA, Ayuk LA, Van Eyck L, et al. Genetic and phenotypic spectrum associated with IFIH1 gain-of-function. Hum Mutat. 2020;41:837\u201349. https:\/\/doi.org\/10.1002\/humu.23975.","journal-title":"Hum Mutat"},{"key":"9700_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.2933","volume":"46","author":"GI Rice","year":"2014","unstructured":"Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GMA, Anderson BH, Ariaudo G, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type i interferon signaling. Nat Genet. 2014;46:503\u20139. https:\/\/doi.org\/10.1038\/ng.2933.","journal-title":"Nat Genet"},{"key":"9700_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1735","volume":"6","author":"MA Hassani","year":"2022","unstructured":"Hassani MA, Murid J, Yan J. Regulator of telomere elongation helicase 1 gene and its association with malignancy. Cancer Rep. 2022;6:e1735. https:\/\/doi.org\/10.1002\/cnr2.1735.","journal-title":"Cancer Rep"},{"key":"9700_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4390789","volume":"2018","author":"X Wang","year":"2018","unstructured":"Wang X, Lei D, Ding J, Liu S, Tao L, Zhang F, et al. A DNA-methylated sight on autoimmune inflammation network across RA, pSS, and SLE. J Immunol Res. 2018;2018:1\u201313. https:\/\/doi.org\/10.1155\/2018\/4390789.","journal-title":"J Immunol Res"},{"key":"9700_CR44","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.1007\/s10067-022-06209-9","volume":"41","author":"SM Al-Mayouf","year":"2022","unstructured":"Al-Mayouf SM, Akbar L, Abdwani R, Ginesi G, Volpi S, Gattorno M, et al. Performance of the EULAR\/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus. Clin Rheumatol. 2022;41:2721\u20137. https:\/\/doi.org\/10.1007\/s10067-022-06209-9.","journal-title":"Clin Rheumatol"},{"key":"9700_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-4-13","volume":"4","author":"JL McGhee","year":"2004","unstructured":"McGhee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr. 2004;4:13. https:\/\/doi.org\/10.1186\/1471-2431-4-13.","journal-title":"BMC Pediatr"},{"key":"9700_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.900055","volume":"13","author":"FC Eldeniz","year":"2022","unstructured":"Eldeniz FC, Gul Y, Yorulmaz A, Guner SN, Keles S, Reisli I. Evaluation of the 10 warning signs in primary and secondary immunodeficient patients. Front Immunol. 2022;13:900055. https:\/\/doi.org\/10.3389\/fimmu.2022.900055.","journal-title":"Front Immunol"},{"key":"9700_CR47","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jaci.2021.10.030","volume":"149","author":"NT Deuitch","year":"2021","unstructured":"Deuitch NT, Yang D, Lee PY, Yu X, Moura NS, Schnappauf O, et al. TNF inhibition in vasculitis management in adenosine deaminase 2 deficiency (DADA2). J Allergy Clin Immunol. 2021;149:1812-16.e6. https:\/\/doi.org\/10.1016\/j.jaci.2021.10.030.","journal-title":"J Allergy Clin Immunol"},{"key":"9700_CR48","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12519-019-00288-6","volume":"16","author":"MP Yu","year":"2019","unstructured":"Yu MP, Xu XS, Zhou Q, Deuitch N, Lu MP. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment. World J Pediatr. 2019;16:575\u201384. https:\/\/doi.org\/10.1007\/s12519-019-00288-6.","journal-title":"World J Pediatr"},{"key":"9700_CR49","doi-asserted-by":"publisher","unstructured":"Subspecialty Group of Immunology, the Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. [Expert consensus on immunoglobulin G replacement therapy in primary immunodeficiency disease]. 2019;57:909\u201312. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2019.12.003.","DOI":"10.3760\/cma.j.issn.0578-1310.2019.12.003"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09700-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09700-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:28:34Z","timestamp":1770190114000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09700-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9700"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09700-y","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"19 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of the Beijing Children\u2019s Hospital ([2021]-E-229-Y) and conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or their legal guardians\/next of kin in accordance with the national legislation and institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}